Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HERAKLES: Neoadjuvant Trastuzumab and Letrozole in HER2+/HR+ Breast Cancer
NCT02214004Phase 2Unknown
- Sponsor
- Gangnam Severance Hospital
- Start
- Mar 2015
- Primary completion
- Mar 2019
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab, letrozole in breast cancer, sponsored by Gangnam Severance Hospital. Status: unknown.
02
Drugs
trastuzumabletrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02214004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02214004.